The major molecular mechanisms underlying wt p53 status in cancer cells are elevation in the Mdm proteins levels (reviewed in Wade et al.6 and Marine et al.10) or a loss of the key activator ARF (reviewed in Sherr22). Here, CDKN2A is linked to cancer.